Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Biomarker And Lab-Based Prediction Scores
Interactive worksheet2 clinical inputsPatient data not stored

Platelet-Lymphocyte Ratio (PLR) Calculator

Platelet–Lymphocyte Ratio (PLR): Explanation and Clinical Context The Platelet–Lymphocyte Ratio (PLR) is a systemic inflammatory marker calculated as the ratio of platelet count to lymphocyte count in peripheral blood. Elevated PLR reflects both an increased platelet count, often associated with pro-thrombotic and inflammatory states, and a relative lymphopenia, indicating impaired immune regulation. PLR has been stu

Interactive worksheet

Clinical inputs

0/2 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

Platelet–Lymphocyte Ratio (PLR): Explanation and Clinical Context The Platelet–Lymphocyte Ratio (PLR) is a systemic inflammatory marker calculated as the ratio of platelet count to lymphocyte count in peripheral blood. Elevated PLR reflects both an increased platelet count, often associated with pro-thrombotic and inflammatory states, and a relative lymphopenia, indicating impaired immune regulation. PLR has been studied as a prognostic marker in cardiovascular diseases, including coronary artery disease, acute myocardial infarction, and heart failure, as well as in malignancies and other systemic inflammatory conditions.

Clinically, PLR can help stratify patients' risk, predict outcomes, and guide therapeutic decision-making in conjunction with other clinical and laboratory parameters. Reference ranges can vary; generally, a PLR between 100–300 is considered normal, while higher values may indicate worse prognosis.

Evidence & references1 primary source mapped
  1. Source 1

    Azab B, et al. Platelet-to-lymphocyte ratio as a predictor of major adverse cardiac events in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2012;34:326–332. doi:10.1007/s11239-012-0745-0 Güngör H, et al. Platelet-to-lymphocyte ratio in cardiovascular disease: a systematic review. Angiology. 2020;71:216–225. doi:10.1177/0003319719895243

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

RDW-CV Index Calculator

Biomarker And Lab-Based Prediction Scores
Interactive worksheet

Systemic Immune-Inflammation Index (SII) Calculator

Biomarker And Lab-Based Prediction Scores
Interactive worksheet

CRP/Albumin Ratio (CAR) Calculator

Biomarker And Lab-Based Prediction Scores
Interactive worksheet

Copeptin-Troponin Composite Model Calculator

Biomarker And Lab-Based Prediction Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.